JPMorgan Chase is boosting buybacks even after CEO Jamie Dimon called the stock expensive
Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess ...
Hosted on MSN17h
Regeneron CEO: We have 40 drugs in development
In an interview on CNBC’s Mad Money, Len Schleifer said Regeneron (REGN) currently has 40 drugs in development representing billions in potential ...
Cramer's Lightning Round: Super Micro Computer is a sell
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Merck CEO: We’re a much broader company than we have been
In an interview on CNBC’s Mad Money, Robert Davis said Merck’s (MRK) current pipeline is the most diversified it has been in recent history.
Cramer's Lightning Round: Arbutus Biopharma is 'the ultimate spec'
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
myinvestingnews4d
The Week’s Investing News Roundup: Cramer Picks, a Rising Robotics Stock, and More
Dividend stocks are a favorite among investors for good reason. Pfizer Inc. ( NYSE: PFE ), United Parcel Service Inc. ( NYSE: UPS ), and other high-yield stocks have the potential to deliver positive ...
Cramer's Lightning Round: AeroVironment is a buy
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Cramer's Mad Dash: Advanced Micro Devices
Ex-pizzaman who rescued 4 kids from house fire reacts to Donald Trump Jr, Musk calling for him to receive Medal of Freedom ...
Cramer's Lightning Round: 'I would be a seller of QuantumScape'
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.